Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: A novel neurometabolic condition responding to folinic acid substitution
Ramaekers, Vincent; Häusler, M.; Opladen, T.et al.
[en] Introduction: Normal brain development and function depend on the active transport of folates across the blood-brain barrier. The folate receptor-1 (FR1) protein is localized at the basolateral surface of the choroid plexus, which is characterized by a high binding affinity for circulating 5-methyltetrahydrofolate (5- MTHF). Patients and Methods: We report on the clinical and metabolic findings among five children with normal neurodevelopmental progress during the first four to six months followed by the acquisition of a neurological condition which includes marked irritability, decelerating head growth, psychomotor retardation, cerebellar ataxia, dyskinesias (choreoathetosis, ballism), pyramidal signs in the lower limbs and occasional seizures. After the age of six years the two oldest patients also manifested a central visual disorder. Known disorders have been ruled out by extensive investigations. Cerebrospinal fluid (CSF) analysis included determination of biogenic monoamines, pterins and 5-MTHF. Results: Despite normal folate levels in serum and red blood cells with normal homocysteine, analysis of CSF revealed a decline towards very low values for 5-methyltetrahydrofolate (5-MTHF), which suggested disturbed transport of folates across the blood-brain barrier. Genetic analysis of the FR1 gene revealed normal coding sequences. Oral treatment with doses of the stable compound folinic acid (0.5-1 mg/kg/day Leucovorin®) resulted in clinical amelioration and normalization of 5-MTHF values in CSF. Conclusion: Our findings identified a new condition manifesting after the age of 6 months which was accompanied by low 5-MTHF in cerebrospinal fluid and responded to oral supplements with folinic acid. However, the cause of disturbed folate transfer across the blood-brain barrier remains unknown.
Disciplines :
Pediatrics Neurology
Author, co-author :
Ramaekers, Vincent ; Division of Paediatric Neurology, Department of Paediatrics, University Hospital Aachen, Pauwelsstraße 30, 52074 Aachen, Germany
Häusler, M.; Division of Paediatric Neurology, Department of Paediatrics, University Hospital Aachen, Pauwelsstraße 30, 52074 Aachen, Germany
Opladen, T.; Division of Paediatric Neurology, Department of Paediatrics, University Hospital Aachen, Pauwelsstraße 30, 52074 Aachen, Germany
Heimann, G.; Division of Paediatric Neurology, Department of Paediatrics, University Hospital Aachen, Pauwelsstraße 30, 52074 Aachen, Germany
Blau, N.; Division of Biochemistry, University Children's Hospital, Zurich, Switzerland
Language :
English
Title :
Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: A novel neurometabolic condition responding to folinic acid substitution
Adams RD, Kubik CS. Subacute degeneration of the brain in pernicious anemia. N Engl J Med 1944; 231: 1-9
Anderson RG, Kamen BA, Rothberg KG, Lacey SW. Potocytosis: sequestration and transport of small molecules by caveolae. Science 1992; 255: 410-411
Atkinson I, Garrow T, Brenner A, Shane B. Human cytosolic folylpoly-γ-glutamate synthase. Methods Enzymol 1997; 281: 134-140
Baethmann M, Wendel U, Hoffmann GF, Gohlich-Ratmann G, Kleinlein B, Seiffert P, Blom H, Voit T. Hydrocephalus internus in two patients with 5,10-methylenetetrahydrofolate reductase deficiency. Neuropediatrics 2000; 31: 314-317
Blau N, Thöny B, Renneberg A, Penzien JM, Hyland K, Hoffmann G. Variant of dihydropteridine reductase deficiency without hyperphenylalaninemia: Effect of oral phenylalanine loading. JIMD 1999; 22: 216-220
Blau N, Duran M, Blaskovics M (eds). Physician's Guide to Laboratory Diagnosis of Metabolic Diseases. Chapter 2: Hyland K et al. Disorders of Neurotransmitter Metabolism. London: Chapman and Hall, 1996: 79-98
Clayton PT, Smith I, Harding B, Hyland K, Leonard JV, Leeming RJ. Subacute combined degeneration of the cord, dementia and Parkinsonism due to an inborn error of folate metabolism. J Neurol Neurosurg Psychiatr 1986; 49: 920-927
Corbeel L, Van den Berghe G, Jaeken J et al. Congenital folate malabsorption. Eur J Pediatr 1985; 143: 284-290
Curtius HC, Blau N, Kuster T. Pterins. In: Hommes FA (ed). Techniques in Diagnostic Human Biochemical Genetics. New York: Wiley-Liss, 1991: 377-396
Czeizel AE, Dudas I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. New Eng J Med 1992; 327: 1832-1835
De Marco P, Moroni A, Merello E et al. Folate pathway gene alterations in patients with neural tube defects. Am J Med Genet 2000; 95: 216-223
Elwood PC, Nachmanoff K, Saikawa Y et al. The divergent 5′ termini of the alpha human folate receptor (hFR) mRNAs originate from two tissue-specific promotors and alternative splicing: characterization of the alpha hFR Gene structure. Biochemistry 1997; 36: 1467-1478
Fan J, Vitols KS, Huennekens FM. Multiple folate transport systems in L 1210 cells. Adv Enzyme Regul 1992; 32: 3-15
Ghosh SK, Syed SK, Jung S, Paik WK, Kim S. Substrate specificity for myelin basic protein-specific protein methylase I. Biochim Biophys Acta 1990; 1039: 142-148
Gospe SM, Gietzen DW, Summers PJ et al. Behavioral and neurochemical changes in folate-deficient mice. Physiol Behav 1995; 58: 935-941
Heil SG, Van der Put NMJ, Trijbels FJM et al. Molecular genetic analysis of human folate receptors in neural tube defects. Eur J Hum Gen 1999; 7: 393-396
Holm J, Hansen SI, Hoier-Madsen M, Bostad L. High-affinity folate binding in human choroid plexus. Biochem J 1991; 280: 267-271
Hyland K, Fryburg JS, Wilson WG et al. Oral phenylalanine loading in dopa-responsive dystonia: a possible diagnostic test. Neurology 1997; 48: 1290-1297
Ichinose H, Ohye T, Matsuda Y et al. Characterization of mouse and human GTP cyclohydrolase I gene mutations in patients with GTP cyclohydrolase I deficiency. J Biol Chem 1995; 270: 10062-10071
Kamen BA, Capdevila A. Receptor-mediated folate accumulation is regulated by the cellular folate content. Proc Natl Acad Sci USA 1986; 83: 5983-5987
Kane MA, Elwood PC, Portillo RM, Antony AC, Najfeld V, Finley A, Waxman S, Kolhouse JF. Influence on immunoreactive folate-binding protein of extracellular folate concentration in cultured human cells. J Clin Invest 1988; 81: 1398-1406
Lever EG, Elwes RDC, Williams A, Reynolds EH. Subacute combined degeneration of the cord due to folate deficiency: response to methyl-folate treatment. J Neurol Neurosurg Psychiatr 1986; 49: 1203-1207
Mineo C, Anderson RGW. Potocytosis. Robert Feulgen lecture. Histochem Cell Biol 2001; 116: 109-118
Piedrahita JA, Oetama B, Bennett GD, van Waes J et al. Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. Nature genetics 1999; 23: 228-232
Prasad PD, Ramamoorthy S, Moe AJ et al. Selective expression of the high-affinity isoform of the folate receptor (FR-alpha) in the human placental syncytiotrophoblast and choriocarcinoma cells. Biochim Biophys Acta Molecular Cell Res 1994; 1223: 71-75
Ramaekers V Th, Senderek J, Häusler M et al. A novel neurodevelopmental syndrome responsive to 5-hydroxytryptophane and carbidopa. Mol Genet Metab 2001; 73: 179-187
Rosenblatt D. Inherited disorders of folate transport and metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The Metabolic and Molecular Basis of Inherited Disease. 7th ed. New York, NY: McGraw-Hill, 1995: 3111-3128
Rothberg KG, Ying Y, Kolhouse JF et al. The glycophospholipid-linked folate receptor internalizes folate without entering the clathrin-coated pit endocytotic pathway. J Cell Biology 1990; 110: 637-649
Said HM, Nguyen TT, Dyer DL et al. Intestinal folate transport: identification of a cDNA involved in folate transport and the functional expression and distribution of its mRNA. Biochim Biophys Acta Biomembranes 1996; 1281: 164-172
Selhub J. Folate binding proteins. Mechanism for placental and intestinal uptake. In: Allen L, King J, Lönnerdal B (eds). Nutrient Relation During Pregnancy, Lactation and Infant Growth. New York: Plenum Press, 1994; 141-149
Shen F, Ross JF, Wang X et al. Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells -cDNA cloning, expression, immunoreactivity and tissue specificity. Biochemistry 1994; 33: 1209-1215
Spector R, Lorenzo A. Folate transport in the central nervous system. Am J Physiol 1975; 229: 777-782
Spector R. Micronutrient homeostasis in mammalian brain and cerebrospinal fluid. J Neurochem 1989; 53: 1667-1674
Surtees R. Biochemical pathogenesis of subacute combined degeneration of the spinal cord and brain. JIMD 1993; 16: 762-770
Surtees R, Heales S, Bowron A. Association of cerebrospinal fluid deficiency of 5-methyltetrahydrofolate, but not S-adenosylmethionine, with reduced concentrations of the acid metabolites of 5-hydroxytryptamine and dopamine. Clin Sci (Colch) 1994; 86: 697-702
Urbach J, Abrahamor A, Grossowicz N. Congenital isolated folic acid malabsorption. Arch Dis Child 1987; 62: 78-80
Wang TTY, Chandler CJ, Halsted CH. Intracellular pteroylpolyglutamate hydrolase from human jejunal mucosa: isolation and characterization. J Biol Chem 1986; 261: 13551-13555
Wang Y, Zhao R, Russell RG, Goldman ID. Localization of the murine reduced folate carrier as assessed by immunohistochemical analysis. Biochim Biophys Acta 2001; 1513: 49-54
Weitman SD, Lark RH, Coney LR, Fort DW, Frasca V, Zurawski VR, Kamen BA. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res 1992; 52: 3396-3401
Weitman SD, Weinberg AG, Coney LR et al. Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis. Cancer Res 1992; 52: 6708-6711
Wevers RA, Hansen SI, Hubar JLMV et al. Folate deficiency in cerebrospinal fluid associated with a defect in folate binding protein in the central nervous system. J Neurol Neurosurg Psychiatr 1994; 57: 223-226
Wu D, Pardridge WM. Blood-brain barrier transport of reduced folic acid. Pharm Res 1999; 16: 415-419
Young SN. The 1989 Borden Award Lecture. Some effects of dietary components (amino acids, carbohydrate, folic acid) on brain serotonin synthesis, mood, and behavior. Can J Physiol Pharmacol 1991; 69: 893-903
